Further to yesterday's post, a correspondent to Radio 4's PM programme revealed that Westminster health minister Matt Hancock had intervened when the Oxford University vaccine research team proposed to partner up with a US company to produce their vaccine. He judged that the UK government - and indeed Europe - needed more control over future supplies and instead brokered a marriage with AstraZeneca, the Anglo-Swedish company headquartered in Cambridge.
As to Pfizer, an industry commentator stated that the prices that the American company obtained for the BioNTech vaccine were $14 a shot in the UK, $19 in the EU and $28 for Israel.
No comments:
Post a Comment